Literature DB >> 19822276

A community population survey of prevalence and severity of dyspnea in adults.

David C Currow1, John L Plummer, Alan Crockett, Amy P Abernethy.   

Abstract

Given the progress in the symptomatic treatment of breathlessness, and the physical and psychological morbidity associated with chronic breathlessness, estimates of the size of the population that may benefit from better support become imperative. Prevalence estimates have varied widely (0.9% of clinical encounters to 32%) and have largely relied only on respondents who used clinical services. Whole-of-population approaches may be able to define better the "true" prevalence of chronic breathlessness and quantify exertion limited by breathlessness. The aim of this study was to estimate population levels of chronic breathlessness, severity of limits to exercise, and demographic predictors of the presence of breathlessness. A whole-of-population face-to-face survey method (n=8,396) in South Australia was used, directly standardized for age, gender, country of birth, and rurality. Respondents were asked about breathlessness and levels of exertion causing breathlessness for at least three of the last six months using a modified Medical Research Council dyspnea scale. Univariate and multivariate analyses identify the demographic characteristics of people more likely to experience chronic breathlessness. With a participation rate of 65.3%, 8.9% of respondents had breathlessness that chronically limited exertion. Significant associations with chronic breathlessness in multivariate analysis included female sex (P<0.001), not working full time (P<0.001), low income (P=0.007), and older age (P=0.031). There are significant levels of chronic breathlessness in the community. Given the prevalence, it is feasible to explore the onset of breathlessness, the underlying etiologies and subsequent health service utilization, and health consequences.

Entities:  

Mesh:

Year:  2009        PMID: 19822276     DOI: 10.1016/j.jpainsymman.2009.01.006

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  37 in total

1.  The patient with dyspnea. Rational diagnostic evaluation.

Authors:  S Brenner; G Güder
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 2.  [Management of refractory breathlessness in patients with advanced disease].

Authors:  C Bausewein
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

Review 3.  Patient-Reported Outcome Measures in Upper Airway-Related Dyspnea: A Systematic Review.

Authors:  Meaghan Noud; Kristen Hovis; Alexander Gelbard; Nila A Sathe; David F Penson; Irene D Feurer; Melissa L McPheeters; David O Francis
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-08-01       Impact factor: 6.223

4.  The Trajectory of Dyspnea in Hospitalized Patients.

Authors:  Ernest DiNino; Mihaela S Stefan; Aruna Priya; Benjamin Martin; Penelope S Pekow; Peter K Lindenauer
Journal:  J Pain Symptom Manage       Date:  2015-11-24       Impact factor: 3.612

5.  The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.

Authors:  David C Currow; Stephen Quinn; Aine Greene; Janet Bull; Miriam J Johnson; Amy P Abernethy
Journal:  J Palliat Med       Date:  2013-06-08       Impact factor: 2.947

6.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

Review 7.  Opioids for chronic refractory breathlessness: right patient, right route?

Authors:  David C Currow; Magnus Ekstrom; Amy P Abernethy
Journal:  Drugs       Date:  2014-01       Impact factor: 9.546

8.  Molecular characterization of Arabidopsis PHO80-like proteins, a novel class of CDKA;1-interacting cyclins.

Authors:  J A Torres Acosta; J de Almeida Engler; J Raes; Z Magyar; R De Groodt; D Inzé; L De Veylder
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

9.  Sex differences in the intensity and qualitative dimensions of exertional dyspnea in physically active young adults.

Authors:  Julia M Cory; Michele R Schaeffer; Sabrina S Wilkie; Andrew H Ramsook; Joseph H Puyat; Brandon Arbour; Robbi Basran; Michael Lam; Christian Les; Benjamin MacDonald; Dennis Jensen; Jordan A Guenette
Journal:  J Appl Physiol (1985)       Date:  2015-09-03

Review 10.  [Dyspnea : A challenging symptom in the primary care setting].

Authors:  Georg Fröhlich; Kai Schorn; Heike Fröhlich
Journal:  Internist (Berl)       Date:  2020-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.